Monthly Archives: May 2013

Featured Stories

64 More Plavix Patients File Suit Over Bleeding Side Effects

Another Plavix lawsuit has been filed on behalf of 64 Plavix patients who allege bleeding side effects. Plavix (clopidogrel) is a blood thinner prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side effects, such as the heart attacks and strokes it is ...

Read More

DeflateGate’s Effects Impact Legal Gambling and the Economy

DeflateGate’s Effects Impact Legal Gambling and the Economy

The NFL has initiated a probe into the New England Patriots following allegations that the team intentionally used overly deflated footballs.

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

Lawsuit Alleges Plavix Caused Oklahoma Man to Suffer Multiple Stomach Bleeds

Another lawsuit has been filed over adverse Plavix side effects. The lawsuit, filed by national law firm Parker Waichman LLP, alleges that the blood thinner, Plavix (clopidogrel), caused an Oklahoma man to suffer from multiple stomach bleeds.

Read More

Government Penalizes 721 Hospitals for High Rates of Infections, Injuries

Medicare is reducing payments to 721 hospitals, one out of every seven hospitals in the nation, for having high rates of “hospital-acquired” conditions (HAC.

Read More

Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million

Bayer AG reported yesterday that it continues to settle Yaz and Yasmin birth control pill lawsuits. According to a report from Bloomberg News, the company said in its latest Stockholder Newsletter that it has settled 651 Yaz and Yasmin blood clot lawsuits for a total of $147 million. The average ...

Read More

Medtronic Infuse Lawsuit Alleges Off-Label Use Cause Painful Complications

A man in Louisiana has filed suit against Medtronic Inc. over injuries allegedly cause by off-label use of its Infuse Bone Graft product. The plaintiff, who received Infuse during transforaminal spinal lumbar fusion surgery, claims that the bone growth protein caused unwanted bone growth along his spine, worsening the back ...

Read More

What Action Will the FDA Take on E-cigarettes?

What Action Will the FDA Take on E-cigarettes?

As health and quality concerns trouble the e-cigarette industry, experts and the public await the Food and Drug Administration (FDA)’s action to regulate the devices.

Read More

Yale’s Infuse® Bone Graft Study Expected in June

Yale_Infuse_Bone_Graft_study

A Yale University report concerning the bone graft product Infuse® is expected out next month. Device maker, Medtronic, commissioned Yale University researchers to conduct independent studies of its Infuse® bone graft products, allegedly in response to a June 2011 report … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Blood Cancer, Rheumatoid Arthritis Drug, MabThera, Linked to Severe Skin Reactions

Mabthera-Skin-Reactions

Roche Products Limited just issued a letter to healthcare providers in cooperation with the European Medicines Agency (EMA) and the Medicines and Healthcare products Regulatory Agency (MHRA) concerning the use of MabThera (rituximab) and severe skin reactions. According to Roche, … Continue reading

Posted in Health Concerns, Pharmaceuticals |

Januvia, Byetta, Other Diabetes Drugs Focus of Controversy

Januvia_Diabetes

Some popular and money making diabetes drugs are at the center of a conflict over disturbing research findings. Although Dr. Peter C. Butler declined to test its then-new diabetes medication, Januvia, he ultimately relented and, in 2008, observed that the … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

Supreme Court of New Jersey Centralizes Mirena® IUD Litigation

Mirena_NJ_Supreme_Court

The Supreme Court of New Jersey just reconsidered a prior decision and is centralizing all Mirena® intrauterine device (IUD) litigation in Bergen County, New Jersey. This will enable the process to move more efficiently given that many of the plaintiffs … Continue reading

Posted in Defective Medical Devices, Mirena IUD |

Study: Zyprexa, Other Antipsychotics, Associated with Increased Risks for Torsade de Pointes

Zyprexa_Torsade

A recent study has found that some antipsychotic drugs were associated with increased risks for developing torsade de pointes (TdP), a type of abnormal heart rhythm, and other adverse events. Zyprexa was among the drugs studied. For their research, the … Continue reading

Posted in Pharmaceuticals |

EPA Proposes Stricter Rules over Formaldehyde Exposure

Formaldyhyde-Exposure

The U.S. Environmental Protection Agency (EPA) just proposed two rules to protect Americans from exposure to the harmful chemical, formaldehyde. The rules are consistent with a 2010 Federal law unanimously passed by Congress. The rules ensure that domestically produced or … Continue reading

Posted in Health Concerns, Legal News, Toxic Substances |

Wal-Mart Pleads Guilty to Federal Environmental Crimes, Civil Violations, to Pay More Than $81 Million

Walmart_Pleads_Guilty

Wal-Mart has admitted to violating criminal and civil laws meant to protect water quality and ensure proper handling of hazardous wastes and pesticides, the Environmental Protection Agency (EPA) announced. The retailer pleaded guilty to six counts of violating the Clean … Continue reading

Posted in Health Concerns, Legal News, Toxic Substances |

Experts Question Drugmakers’ Push to Treat Low Testosterone

Low-Testoterone

Drugmakers are lavishing millions of dollars on ads promoting the wonders of testosterone treatment, but they overhype the benefits and underplay the risks, according to Consumer Reports magazine. The print and television ads, primarily for two products, AndroGel and Axiron, … Continue reading

Posted in Health Concerns, Pharmaceuticals |

Study: Pesticide Exposure Increases Risks for Parkinson’s Disease

Pesticide_Exposure

For not the first time, a study suggests a link between Parkinson’s disease and pesticide exposure. Parkinson’s disease is a progressive, degenerative central nervous system disorder that typically affects motor skills and speech, among other functions and, while not fatal, … Continue reading

Posted in Health Concerns, Paraquat, PCBs, Perchlorate, Toxic Substances |

Yale’s Medtronic Reporting Expected Next Month

Yale_Medtronic_Reporting

As the fallout from a conflict-of-interest scandal continues, drug maker Medtronic, announced in its fiscal fourth-quarter earnings report that the results from a long-awaited Yale review are expected to be published next month. Medtronic has been the focus of a … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.